Scientists have made significant strides in understanding brain aging in Alzheimer's disease. They have investigated a treatment that works directly in the brain to counteract harmful processes. This research focuses on activating the immune system in the brain to more effectively remove toxic protein accumulations and damaged cells.
A protein called PD-L1 plays a role in suppressing the immune system. Some cancer cells use this protein to escape destruction. By administering a drug that blocks PD-L1 directly to the brain in mice with Alzheimer’s, brain cells improved their function. This could be an important step in reducing inflammation and cell damage in the brain.
In addition to this research, attention is also being paid to medications that affect the mTOR system, a key factor in cell metabolism and aging. Although inhibiting mTOR in animal models can extend lifespan, the effect in humans is still uncertain. Perhaps such drugs could in the future improve cell maintenance and thus support brain health.
These studies emphasize that addressing the various aging processes in the brain is crucial. By improving understanding and developing new treatments, memory loss associated with aging can potentially be slowed down. This contributes to healthy aging.
Source: Reason
